EFTA01113739Set 9
37p2,922w
status in colon cancer
OSE1101 reprofiling a molecule previously marketed
1. safety package
2. H4R agonist patent in the US
3. Cystic Fibrosis Patent filed in 2012
OSE
EFTA01113743 ... life-limiting disease (median survival : 36.9 years)
OSE1101 is a new anti-inflammatory molecule (H4R agonist/IL8 decrease)
Maintaining lung function
Mucolytic agents (i.e. dornase alfa ,Pulmozyme®)
Nebulized, inhaled, oral ... Australia)
OSE Pba—is
EFTA01113762
OSE 1101 in Cystic Fibrosis
■ OSE1101 as a new H4R agonist & histamine modulator
■ Role on histamine level and interleukin release
https://www.justice.gov/epstein/files/DataSet%209/EFTA01113739.pdf
EFTA02404275Set 11
2012-12-27237p7,807w
AC100400C1—H.E.H.M.H.A.H. I rP.H.40+L.E.I.H.E.I.@:14H+H.
0 840S(10•HAIS FI0000.1I.T$CIA.
H.V.t H4r lem Q..H..+H.E.H ... ADAiHAAAODA
4>H04.(DO,H44,H4,40,74..H.,t He•OP-H.,(...HeetHeet
H4r*.P.71, AAHAOXIA"A_IflAAAAAAAAAAOOUHOQAVSE1QAOlAAtrAOHOAHAAt%1HAAA
nneOH, 49,He t leHeC(HOC H.C I..L..[AAjeleeHeelreeLee
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02404275.pdf